Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations

References

• Attia M, El-Gibaly I, Shaltout S, Fetih G. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int J Pharm 2004; 276: 11–28
   PubMed Web of Science ®Google Scholar
• Bottenberg P, Cleymaet R, Muynek CD, Remon JP, Coomans D, Slop D. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol 1991; 43: 457–64
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JSM. Modeling and comparison of dissolution profile. Eur J Pharm Sci 2001; 13: 123–33
   PubMed Web of Science ®Google Scholar
• Dai S, McNeil JH. Fructose-induced hypertension in rats is concentration and duration dependent. J Pharmacol Toxicol Methods 1995; 33: 101–7
   PubMed Web of Science ®Google Scholar
• Dubey R, Parikh R. Two-stage optimization process for formulation of chitosan microspheres. AAPS PharmSciTech 2004; 5(1)E5. , Article 5
   Google Scholar
• Gohel MC, Jogani PD. Functionality testing of a multifunctional directly compressible adjuvant containing lactose, polyvinylpyrrolidone, and croscarmellose sodium. Pharm Tech 2002; 25: 64–82
   Google Scholar
• Grabovac V, Guggi D, Bernkop-Schnürch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Del Rev 2005; 57: 1713–23
   PubMed Web of Science ®Google Scholar
• Hokama N, Hobara N, Kameya H, Ohshiro S, Sakanashi M. Rapid and simple micro-determination of Carvedilol in rat plasma by high-performance liquid chromatography. J Chromatography 1999; 732: 233–8
   Google Scholar
• Ieggli CV, Cardoso SG, Belle LP. Validation of UV spectrophotometric and nonaqueous titration methods for the determination of Carvedilol in pharmaceutical formulations. J AOAC Int 2005; 5: 1299–303
   Google Scholar
• Iida K, Hayakawa Y, Okamoto H, Danjo K, Leuenberger H. Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier. Chem Pharm Bull 2001; 49: 1326–30
   PubMed Web of Science ®Google Scholar
• Jasti BR, Zhou S, Mehta RC, Li X. Permeability of antisense oligonucleotide through sheep buccal mucosa. Int J Pharm 2000; 208: 35–9
   PubMed Web of Science ®Google Scholar
• Jeyanthi R, Mehta R, Thanoo B, Deluca P. Effect of processing parameters on the properties of peptide-containing PLGA microspheres. J Microencapsulation 1997; 14: 163–74
   PubMed Web of Science ®Google Scholar
• Kitano M, Maitani Y, Takayama K, Nagai T. Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17β-estradiol from hydrogels containing three types of absorption enhancers. Int J Pharm 1998; 174: 19–28
   Web of Science ®Google Scholar
• Ko J, Park H, Hwang S, Park J, Lee J. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm 2002; 249: 165–74
   PubMed Web of Science ®Google Scholar
• Kockisch S, Rees G, Young S, Tsibouklis J, Smart J. Polymeric microspheres for drug delivery to the oral cavity: An in vitro evaluation of mucoadhesive potential. J Pharm Sci 2003; 92: 1614–23
   PubMed Web of Science ®Google Scholar
• Lee RP, Wang D, Lind NT, Chou YW, Chen HI. A modified technique for tail cuff pressure measurement in unrestrained conscious rats. J Biomed Sci 2002; 9: 424–7
   PubMed Web of Science ®Google Scholar
• Ljubin TS, Kocevar K, 2009. Multiple unit tablets, US Patent 0291136 A1, United States of America, November 26
   Google Scholar
• Macleod G, Collett J, Fell J. The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release. J Controlled Release 1999; 58: 303–10
   PubMed Web of Science ®Google Scholar
• Majithiya R, Murthy RSR. Enhancement of mucoadhesion by blending anionic, cationic, non-ionic polymers. Drug Deliv Technol 2008; 8(2)40–5
   Google Scholar
• Maurya SK, Pathak K, Bali V. Therapeutic potential of mucoadhesive drug delivery systems - an updated patent review. Recent Pat Drug Deliv Formul 2010; 4(3)256–65
   PubMedGoogle Scholar
• Miglani DS, 2002. Preparation and evaluation of controlled release oral dosage forms of glipizide and nifedipine. PhD Dissertation, University Institute of Pharmaceutical Sciences, Punjab University, Chandigarh
   Google Scholar
• Miller N, Chittchang M, Thomas P, Johnston P. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Delivery Rev 2005; 57: 1666–91
   PubMed Web of Science ®Google Scholar
• Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet 1994; 26: 335–46
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Shelke NB, Rokhade AP, Patil SA, Aminabhavi TM. Formulation and in-vitro evaluation of novel starch-based tableted microspheres for controlled release of ampicillin. Carbohydr Polym 2008; 71(1)42–53
   Google Scholar
• Patil S, Babbar A, Mathur R, Mishra A, Sawant K. Mucoadhesive chitosan microspheres of carvedilol for nasal administration. J Drug Target 2010; 18(4)321–31
   PubMed Web of Science ®Google Scholar
• Rathbone M, Drummond B, Tucker B. The oral cavity as a site for systemic drug delivery. Adv Drug Delivery Rev 1994; 13: 1–22
   Web of Science ®Google Scholar
• Ritger P, Peppas A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Controlled Release 1987; 5: 37–42
   Google Scholar
• Sandri G, Rossi S, Ferrari F, Bonferoni MC, Muzzarelli CC. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur J Pharm Sci 2004; 21: 351–9
   PubMed Web of Science ®Google Scholar
• Sezer A, Akbuga J. Controlled release of piroxicam from chitosan beads. Int J Pharm 1995; 121: 113–16
   Web of Science ®Google Scholar
• Shiraishi S, Imai T, Otagiri M. Controlled release of indomethacin by chitosan–polyelectrolyte complex: Optimization and in vivo/in vitro evaluation. J Controlled Release 1993; 25: 217–25
   Web of Science ®Google Scholar
• Shukla PG, Kalidhass B, Shah A, Palashkar DV. Preparation and characterization of microcapsules of water soluble pesticide monocrotophos using polyurethane as carrier material. J Microencapsulation 2002; 19: 293–304
   PubMed Web of Science ®Google Scholar
• Sinha V, Singla A, Wadhawan S, Kaushik R, Kumaria R, Bansal K, Dhawan S. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004; 274: 1–33
   PubMed Web of Science ®Google Scholar
• Squier CA, Wertz PW. Structure and function of the oral mucosa and implications for drug delivery. Oral mucosal drug delivery, MJ Rathbone. Marcel Dekker Inc, New York 1996; 1–26
   Google Scholar
• Sweetman SC. Martindale: The complete drug reference, Carvedilol. Pharmaceutical Press, London, UK 2005
   Google Scholar
• Taylor MK, Ginsburg J, Hickey AJ, Gheyas F. Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development. AAPS PharmSciTech 2000; 1(3)20–30, Article 18
   Google Scholar
• Uhumwangho MU, Okor RS. Multi-unit dosage formulations of theophylline for controlled release applications. Acta Pol Pharm Ñ Drug Res 2007; 64(6)553–9
   PubMedGoogle Scholar
• Veuillez F, Kalia YN, Jacques Y, Deshusses J, Buri P. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm 2001; 51: 93–109
   PubMed Web of Science ®Google Scholar
• Vogel WH, Scholkens BA, Sandow J, Muller G, Vogel WF. Cardiovascular activity - Pharmacological assays. Drug discovery and evaluation, GH Vogel. Springer, Berlin, Germany 2002; 176
   Google Scholar
• Weir RA, Dargie HJ. Carvedilol in chronic heart failure: Past, present and future. Future Cardiol 2005; 1: 723–34
   PubMedGoogle Scholar
• Yedurkar PD, Dhiman MK, Sawant KK. Mucoadhesive bilayer tablets for buccal delivery of carvedilol: In vitro and in vivo investigations. Ars Pharm 2007; 48(3)259–74
   Google Scholar